Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

In a statement on the Valo Health alliance, Novo Nordisk pointed to the potential for Opal to predict compound safety and efficacy and said that the collaboration may be extended to cover ...

The revised deal expands the collaboration for up to 20 new drug programs and adds nine new programs in obesity, type 2 diabetes, and cardiovascular disease. It allows Valo to receive roughly $4 ...

Novo Nordisk has almost doubled the scale of an R&D alliance with Valo Health – a specialist in ... with Valo during the first year of our collaboration, and we are excited to expand the scope ...

Ph.D., chief operating officer at Valo Health. "Our collaboration gives us access to nference's deep multimodal, longitudinal data and AI software platform, which will allow us to learn through ...

the result of a strategic collaboration between Charles River and Valo Health, is the industry’s first computation-powered, unified target-to-candidate offering. The platform leverages the ...

Despite remarkable advancements in healthcare technology and ... among clinical trial patients. In collaboration with other teams at Pfizer, ITEM has contributed to additional initiatives ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with Pfizer Inc. (NYSE ... global public health crises, that may affect timing ...

Research collaboration expedites innovation by leveraging synergies between Valo Health's Opal Computational Platform™ and the nference Agentic AI platform CAMBRIDGE, Mass. & LEXINGTON, ...